Medi-Caps (BOM:523144) Beta: 0.7734 (As of Jul. 04, 2026)


BOM:523144 Medi-Caps Ltd BOM:523144
46 GF Score
Price ₹25.93
GF Value ₹20.10
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Medi-Caps Beta?

Medi-Caps BOM:523144 -7.29% 46 Beta is 0.7734 as of Jul. 04, 2026. GuruFocus rates BOM:523144 with a GF Score™ of 46/100 and a GF Value™ of ₹20.10 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-04), Medi-Caps's Beta is 0.7734.


Medi-Caps  (BOM:523144) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medi-Caps Beta Related Terms


Medi-Caps Beta Historical Data

* Premium members only.

The historical data trend for Medi-Caps's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medi-Caps Beta Chart

Medi-Caps Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.36 0.72 0.75 0.65

Medi-Caps Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.72 0.64 0.66 0.65

Medi-Caps Beta Competitor Comparison

For the Real Estate - Diversified subindustry, Medi-Caps's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medi-Caps Beta vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Medi-Caps's Beta distribution charts can be found below:

* The bar in red indicates where Medi-Caps's Beta falls into.


BOM:523144
46GF Score
Medi-Caps Ltd BOM:523144
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medi-Caps Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7734 mean?
Medi-Caps (BOM:523144) has a Beta of 0.7734 as of Jul. 04, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medi-Caps and its competitors.
Is Medi-Caps' Beta too high?
Medi-Caps' current Beta is 0.7734. Overall, Medi-Caps has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medi-Caps' Beta compare to competitors?
Medi-Caps' Beta of 0.7734 can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Real Estate company?
A good Beta depends on the Real Estate industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medi-Caps and its competitors. Medi-Caps's current Beta is 0.7734. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medi-Caps stock overvalued right now?
Based on GuruFocus' analysis, Medi-Caps (BOM:523144) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹20.10, compared to a current price of ₹25.93 — trading 29% above its estimated fair value. The current Beta is 0.7734. Medi-Caps' overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Medi-Caps (BOM:523144), the current Beta is 0.7734 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medi-Caps (BOM:523144) Overvalued in 2026?

Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued. The current stock price of ₹25.93 is trading 29% above its estimated GF Value™ of ₹20.10. GuruFocus considers Medi-Caps to be Modestly Overvalued.

Key valuation signals for BOM:523144:

  • Beta: 0.7734
  • GF Value™: ₹20.10 vs. price of ₹25.93 (29% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the BOM:523144 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medi-Caps Business Description

Address 201, Pushpratna Paradise, 9/5, New Palasia, Opposite UCO Bank, Indore, MP, IND, 452 001
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
46GF Score

Get the complete analysis for BOM:523144

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.93
Price
₹20.10
GF Value